Eur Heart J 44(39):40434140 Neves JS, Leite AR, Mentz RJ, Holman RR, Zannad F, Butler J et al (2025) Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: the EXSCEL trial
According to clinical trials, prescription GLP-1 medications typically lead to 518% weight loss, while studies of high-dose tirzepatide combined with intensive lifestyle support have reported reductions of up to ~25%
Person one absorbs enough active compound to suppress appetite, reduce food noise, and drive meaningful weight loss results
Horowitz M, Aroda VR, Han J, Hardy E, Rayner CK
People who microdose often count clicks to measure out a smaller dose of the med than whats listed on the label, Zimmermann says